Raw Materials & Excipients Management – Page 16

Specification change not communicated during routine operations – CAPA to prevent repeat failures

Identifying symptoms or signals of uncommunicated specification changes is critical. Here are common indicators that may arise in manufacturing or quality control:Click to read the full article.

Inadequate vendor qualification during requalification – inspection questions regulators ask

Investigating Issues with Vendor Qualification During Requalification In the pursuit of maintaining product quality, pharmaceutical manufacturers often face challenges arising from inadequate vendor qualification, particularly during the requalification process. Regulatory…

Supplier change not evaluated during deviation investigation – CAPA to prevent repeat failures

Effectively evaluating supplier changes during deviation investigations is crucial for ensuring compliance and maintaining product quality. By following the outlined playbook, every role within a pharmaceutical organization can contribute to…

Quality agreement gaps during supplier onboarding – how to prevent repeat supplier failures

Preventing Recurrent Failures Linked to Quality Agreement Gaps in Supplier Onboarding In an increasingly complex pharmaceutical landscape, the integrity of raw materials and compliance with Good Manufacturing Practices (GMP) hinge…

Unapproved material substitution during post-approval change review – risk-based change impact assessment

Recognizing early signs of unapproved material substitution is crucial for minimizing disruptions. Common symptoms include:Click to read the full article.

Inadequate vendor qualification during routine supplier audit – audit CAPA remediation framework

During routine supplier audits, various signals may indicate potential inadequacies in vendor qualification processes. Identifying these symptoms early can help mitigate risks before they escalate. Common indicators include:Click to read…

Raw material change implemented without assessment during deviation investigation – risk-based change impact assessment

Recognizing the early symptoms of unassessed raw material changes is crucial. Symptoms may manifest at various stages of the production or laboratory processes. Key signs include:Click to read the full…

Vendor change implemented without approval during requalification – inspection questions regulators ask

Identifying signals that indicate an unapproved vendor change is critical for timely action. Common symptoms may include:Click to read the full article.

Change control documentation gaps during deviation investigation – risk-based change impact assessment

Identifying the symptoms and signals indicating gaps in change control documentation is paramount. Common indicators may manifest at various levels, such as:Click to read the full article.

Quality agreement gaps during supply disruption – audit CAPA remediation framework

Effective monitoring of symptoms or signals during routine operations is critical for early detection of quality agreement gaps. Symptoms can be classified into two categories: operational indicators and quality signals.Click…

Unapproved material substitution during supplier change – preventing batch rejection and recalls

Identifying symptoms of unapproved material substitutions is crucial for early intervention. Here are some common signals that may indicate a material mix-up:Click to read the full article.

Audit response ineffective during routine supplier audit – evidence pack for vendor oversight

Recognizing the symptoms of ineffective audit responses requires keen observation and detailed documentation. Potential signals include:Click to read the full article.